Annual Revenue (£)

Shire revenue was £42.95 m in FY, 2018

Quarterly Revenue ($)

FY, 2016FY, 2017FY, 2018
Revenue£11.4 b$15.16 b£42.95 m
Q1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q1, 2015Q3, 2015Q1, 2016Q2, 2016Q2, 2017Q2, 2018Q3, 2018
Revenue$816.2 m$849.4 m$874.3 m$972.2 m$1.06 b$1.09 b$1.17 b$1.21 b$1.1 b$1.16 b$1.27 b$1.24 b$1.35 b$1.49 b$1.66 b$1.71 b$2.43 b$3.75 b$3.92 b$3.87 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Shire revenue breakdown by business segment: 26.2% from Hematology, 10.0% from Genetic Diseases, 18.4% from Neuroscience, 30.2% from Immunology, 11.6% from Internal Medicine and 3.6% from Other

FY, 2017FY, 2015FY, 2016
Hematology$3.79 b$2.24 b
Neuroscience$2.66 b$2.2 b$2.49 b
Internal Medicine$1.67 b$1.5 b$1.76 b
Oncology$261.7 m$130.5 m
Ophthalmology$259.2 m$54.4 m
Genetic Diseases$1.44 b$1.34 b$1.39 b
Immunology$4.37 b$1.06 b$2.83 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu